ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound.
Date
2020-06-01ICR Author
Author
Abramowicz, JS
Basseal, JM
Brezinka, C
Dall'Asta, A
Deng, J
Harrison, G
Lee, JCS
Lim, A
Maršal, K
Miloro, P
Poon, LC
Salvesen, KÅ
Sande, R
Ter Haar, G
Westerway, SC
Xie, MX
Lees, C
Type
Journal Article
Metadata
Show full item recordCollections
Subject
COVID-19
Coronavirus Infections
Equipment Contamination
Eye Protective Devices
Female
Gloves, Protective
Gynecology
Hand Hygiene
Health Personnel
Humans
Infectious Disease Transmission, Patient-to-Professional
Infectious Disease Transmission, Professional-to-Patient
Masks
Mass Screening
Obstetrics
Pandemics
Personal Protective Equipment
Pneumonia, Viral
Pregnancy
Respiratory Protective Devices
Triage
Ultrasonography
Ultrasonography, Prenatal
Ventilation
Research team
Therapeutic Ultrasound
Language
eng
Date accepted
2020-06-01
License start date
2020-06-01
Citation
Ultrasound in Obstetrics and Gynecology, 2020, 55 (6), pp. 886 - 891
Publisher
WILEY
Related items
Showing items related by title, author, creator and subject.
-
Reusable respirators as personal protective equipment during ENT surgery.
Patel, B; Hardman, JC; Yang, W; Robson, A; Putnam, G; et al.Background Robust personal protective equipment is essential in preventing the transmission of coronavirus disease 2019 to head and neck surgeons who are routinely involved in aerosol generating procedures.Objective This ... -
Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial, E; Marshall, CJ (2003-12)The AP-1 (activator protein-1) complex, which consists of proteins of the Fos and Jun families, is thought to play an important role in the balance between cell proliferation and apoptosis, the response to genotoxic stress ... -
The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.
Barazas, M; Annunziato, S; Pettitt, SJ; de Krijger, I; Ghezraoui, H; et al. (2018-05)Selective elimination of BRCA1-deficient cells by inhibitors of poly(ADP-ribose) polymerase (PARP) is a prime example of the concept of synthetic lethality in cancer therapy. This interaction is counteracted by the restoration ...